9 Medical Devices Stocks to Buy Now

Advertisement

Nine Medical Devices stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an “A” (“strong buy”) or “B” overall (“buy”).

Winner Medical Group (NASDAQ:WWIN) is progressing from last week’s rating of B (“buy”) as the company improves to an A (“strong buy”) this week. Winner Medical Group engages in the research, development, manufacture, and marketing of cotton-base medical dressings and medical disposables. For more information, get Portfolio Grader’s complete analysis of WWIN stock.

CareFusion (NYSE:CFN) is bettering its rating of C (“hold”) from last week to a B (“buy”) this week. CareFusion is a medical technology company with products and services designed to improve the safety and quality of healthcare. Shares of CFN have increased 5.3% over the past month, better than the 3.1% increase the S&P 500 has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of CFN stock.

Teleflex (NYSE:TFX) improves from a C to a B rating this week. Teleflex offers healthcare providers medical technology products that enable them to improve patient outcomes, reduce infections and enhance patient and provider safety. Wall Street has pushed the stock higher by 5.5% over the past month. For more information, get Portfolio Grader’s complete analysis of TFX stock.

C.R. Bard (NYSE:BCR) shows solid improvement this week. The company’s rating rises from a C to a B. C. R. Bard is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. Investors have pushed the stock price up 6.5% over the past month. For more information, get Portfolio Grader’s complete analysis of BCR stock.

This week, Conceptus’ (NASDAQ:CPTS) ratings are up from a B last week to an A. Conceptus designs, develops, and markets minimally invasive devices for reproductive medical applications primarily in the United States, France, and rest of Europe. For more information, get Portfolio Grader’s complete analysis of CPTS stock.

SurModics (NASDAQ:SRDX) gets a higher grade this week, advancing from a B last week to an A. SurModics offers drug delivery and surface modification technologies to the healthcare industry. Wall Street seems to agree with the upgrade and has propelled the stock up 14.9% over the past month. For more information, get Portfolio Grader’s complete analysis of SRDX stock.

STERIS Corp. (NYSE:STE) is seeing ratings go up from a C last week to a B this week. STERIS provides products and services related to infection prevention and surgical procedures. Wall Street has pushed the stock higher by 7.8% over the past month. For more information, get Portfolio Grader’s complete analysis of STE stock.

The rating of Thoratec (NASDAQ:THOR) moves up this week, rising from a C to a B. Thoratec is involved in the development, manufacture and marketing of proprietary medical devices used for circulatory support. For more information, get Portfolio Grader’s complete analysis of THOR stock.

ArthroCare (NASDAQ:ARTC) earns a B this week, jumping up from last week’s grade of C. ArthroCare is a multi-business medical device Company that develops, manufactures and markets minimally invasive surgical products, many of which are based on its patented Coblation(r) technology. Investors have pushed the stock price up 9.3% over the past month. For more information, get Portfolio Grader’s complete analysis of ARTC stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2013/01/9-medical-devices-stocks-to-buy-now-wwin-cfn-tfx/.

©2024 InvestorPlace Media, LLC